Hopefully and that is a deliberate word choice, Mr Blackburn can leverage sone fast moving contacts in the healthcare area and get cooling in wheel chairs etc, as indicated some years ago. If they could include anti-bacterial in the stick on sheets, there is potential use in the sector without to much change in the current manufacturing. This would also help assist the stock in a market downturn and not be so dependent on retail sales. Alas Healthcare usually moves at Government speed, so it is a "hopefully". If they want Mr Blackburn to wrap up the company and sell it off so all those with shares still get something out of it e.g. directors Then he might also be the cheapest person with experience for the job. Its difficult to see any major positive announcements coming out in the next couple of weeks with Brookins stepping down (some might say its just difficult to see any positive announcements) until at least Mr Blackburn arrives in his new role next month. Us retail sales (due out 17/8/2022) are forecast to be the same as last quarter so not sure top of bed has been moving to well this quarter. Interesting times ahead especially for the companies that have propped up AJX expecting at least a return of investment. Good luck all holders (another deliberate word).
AJX Price at posting:
2.4¢ Sentiment: Buy Disclosure: Held
